Limited (the “Company”) submitted its separate financial statement and its consolidated financial statement for the third quarter of 2019 ended on 30 September 2019 which were reviewed by the auditor. The

“Company”) submitted its separate financial statement and its consolidated financial statement for the first quarter of 2019 ended on 31 March 2019 which were reviewed by the auditor. The Company hereby

Limited (the “Company”) submitted its separate financial statement and its consolidated financial statement for the year of 2019 ended on 31 December 2019 which was audited by the auditor. The Company

: Thousand Baht) For the three-month periods ended 31 March Consolidated financial statements Separate financial statements Transfer pricing policy 2019 2018 2019 2018 Transactions with subsidiaries

last year (YE 2018: Baht 345 million). Whereas the separate financial statement presented the loss on impairment of Baht 360 million consisting of impairment of investment in subsidiary is Baht 10

: THB 2,415 million). 3 Whereas the separate financial statement presented the loss on impairment of THB 701 million consisting of impairment of investment in subsidiary is THB 437 million and loss on

% to sales in Q3/2017 was 28.2% increased by 4.8% compared to the same period at the previous year. 6 Loss on impairment of investment in subsidiary In Separate Financial Statement, Loss on impairment of

2017 ended June 30, 2017. Such financial statements comprise of the consolidated financial statements and the separate financial statements as compared with the financial statements for the first six

. However, the Company still maintained effective operating cost control with cost to income ratio at 38% of total revenues. Considering the Company’s separate financial statement, the operating and

September 2019: Separate Financial Statement for the third quarter, the last 3 months end on 30 September 2019. The net profit is 0.16 million Baht which is less than the previous quarter up to 3.27 million